-
MTNB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Matinas BioPharma (MTNB)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.55 mm | 10.55 mm | 10.55 mm | 10.55 mm | 10.55 mm | 10.55 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.46 mm | 1.83 mm | 1.17 mm | 1.41 mm |
Cash used (since last report) | n/a | n/a | 7.42 mm | 9.32 mm | 5.93 mm | 7.18 mm |
Cash remaining | n/a | n/a | 3.12 mm | 1.22 mm | 4.62 mm | 3.36 mm |
Runway (months of cash) | n/a | n/a | 2.1 | 0.7 | 4.0 | 2.4 |
13F holders | Current |
---|---|
Total holders | 23 |
Opened positions | 7 |
Closed positions | 3 |
Increased positions | 1 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 192.97 mm |
Total shares | 11.60 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vivo Opportunity | 5.99 mm | $7.67 mm |
Vivo Capital IX | 5.27 mm | $7.17 mm |
Vanguard | 106.49 k | $54.31 mm |
Sargent Investment | 64.20 k | $38.39 mm |
BlackRock | 49.65 k | $25.32 mm |
Geode Capital Management | 43.47 k | $22.17 mm |
Susquehanna International | 23.80 k | $12.14 mm |
Renaissance Technologies | 18.17 k | $9.27 mm |
STT State Street | 15.32 k | $7.81 mm |
UBS UBS | 12.31 k | $6.28 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Dec 23 | Matkovits Theresa | Stock Option Common Stock | Grant | Acquire A | No | No | 0.247 | 1,300,000 | 321.10 k | 1,300,000 |